What is strongly supported: Promoter-proximal pausing by NELF/DSIF and release by P-TEFb/CDK9 are well established; CTD phosphorylation coordinates capping, elongation, splicing, 3 end processing, and chromatin marks.
What is context-dependent: Pausing is gene- and stimulus-specific; CTD marks are combinatorial and not a simple linear code.
What is weak, controversial, or assay-biased: “CTD code” can be too deterministic; reader recruitment is dynamic and redundant.
What may be duplicate biology under another name: Overlaps with SHIELD/SPLICER/TRIMMER/STAMP/WRITER-A via co-transcriptional coupling.
Missing or excessive graph structure
Missing edges: Add SCRIBE -> RECODER only indirectly? ADAR editing is often nuclear/co-transcriptional but more substrate/dsRNA-driven.
Excess edges: SCRIBE -> STAMP as CTD recruits METTL3/14 is supported but should be caveated as not all m6A is strictly co-transcriptionally determined by CTD.
Candidate splits: No split.
Candidate merges: No merge.
Candidate renames: POL-II would be clearer but SCRIBE is fine.
Recommendation
Concrete graph change, if any: Keep; caveat CTD-code determinism and pausing generality.
Concrete technical-notes/blog wording change, if any: Mirror the graph recommendation in the glossary and relation catalogue, and explicitly mark the confidence/caveat where the claim is context-dependent or assay-sensitive.
Key sources
PMID 24704787 — Pol II pausing control review.
PMID 31332364 — CTD phosphorylation and co-transcriptional processing review.
PMID 28985512 — transcription elongation coupling to chromatin/RNA processing.
PMID 35090588 — modern review of promoter-proximal pausing and release.